SIRT1 Modulators in Experimentally Induced Liver Injury

Area of Science:

• Biochemistry
• Pharmacology
• Hepatology

Background:

• Silent information regulator T1 (SIRT1) is an endogenous stress sensor implicated in cellular protection.
• Selective SIRT1 modulators (activators and inhibitors) are under investigation for therapeutic potential.
• The role of SIRT1 in liver injury induced by hepatotoxic agents requires further elucidation.

Purpose of the Study:

• To investigate the involvement of SIRT1 in hepatoprotection against chemical-induced liver injury in rats.
• To explore the effects of SIRT1 modulators, including activators like SRT1720, resveratrol, and quercetin, on liver injury.
• To understand the relationship between SIRT1 expression levels and its cytoprotective or cytotoxic effects in the liver.

Main Methods:

• Induction of acute hepatotoxicity using D-galactosamine and lipopolysaccharide (D-GalN/LPS) in rats.
• Induction of subchronic hepatotoxicity using carbon tetrachloride in rats.
• Administration of SIRT1 activators (SRT1720, resveratrol, quercetin) and assessment of liver injury markers and antioxidant enzymes.

Main Results:

• SIRT1 activators upregulated SIRT1 expression and alleviated D-GalN/LPS-induced acute hepatotoxicity, showing an inverse relationship between liver injury markers and SIRT1 levels.
• Quercetin mitigated carbon tetrachloride-induced subchronic hepatotoxicity by modulating SIRT1 expression and restoring antioxidant enzymes.
• Polyphenols fine-tuned SIRT1 expression towards normal levels, suggesting cytoprotective effects occur within a specific expression range.

Conclusions:

• Pharmacologic modulation of SIRT1, particularly with polyphenols, demonstrates significant hepatoprotective effects in both acute and subchronic liver injury models.
• The catalytic activity of SIRT1 is crucial for the hepatoprotective effects of polyphenols, with inhibitors blocking and allosteric activators mimicking these effects.
• Targeting SIRT1 represents a promising therapeutic strategy for treating xenobiotic-induced hepatotoxicity.